Portfolio company
MEPSGEN
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
MEPSGEN develops automated microphysiological systems and nanoparticle manufacturing platforms for pharmaceutical companies, biotech firms, and research laboratories to improve drug development and delivery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Orgonex
Orgonex develops automated bioreactor systems for organoid cultivation to assist researchers and pharmaceutical companies with large-scale cell expansion and drug development.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
TTOP
TTOP develops modular microphysiological platforms and culture modules for researchers to replicate human biology and conduct predictive in-vitro drug testing and tissue modelling.
CN-Bio
This company develops organ-on-a-chip microphysiological systems and consumables for pharmaceutical, biotechnology and regulatory customers to improve drug discovery and preclinical testing.
Polyphron
Polyphron manufactures donor-diverse human tissues and develops AI simulation models to help biotechnology and pharmaceutical companies test drug candidates and biological predictions.
MISO Chip
This company develops microfluidic tumor-on-a-chip platforms for biopharmaceutical firms and academic researchers to conduct preclinical ex vivo drug testing on human tissue models.
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
